{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:16:00Z","timestamp":1761581760853,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.drugalcdep.2018.09.026","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T02:17:12Z","timestamp":1541211432000},"page":"101-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Hepatitis C virus genotype diversity and distribution among methadone maintenance treatment patients in Jiangsu, China"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-8467","authenticated-orcid":false,"given":"Jing","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12072-015-9629-x","article-title":"A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan","volume":"9","author":"Bennett","year":"2015","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0010","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1128\/JCM.43.8.3624-3629.2005","article-title":"Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France","volume":"43","author":"Cantaloube","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0015","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/jmv.22099","article-title":"The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong","volume":"83","author":"Chan","year":"2011","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0020","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1038\/emi.2017.77","article-title":"Hepatitis C virus genotypes and subtypes circulating in Mainland China","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0025","article-title":"Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection","volume":"13","author":"Cheng","year":"2018","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2018.09.026_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jgh.12220","article-title":"Update on epidemiology of hepatitis B and C in China","volume":"28","author":"Cui","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5501\/wjv.v5.i4.170","article-title":"Geographic integration of hepatitis C virus: a global threat","volume":"5","author":"Daw","year":"2016","journal-title":"World J. Virol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcv.2012.04.017","article-title":"Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China","volume":"54","author":"Du","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0045","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/j.gastro.2015.07.063","article-title":"Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection","volume":"149","author":"Gane","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0050","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1053\/j.gastro.2017.01.017","article-title":"Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 weeks in patients with hepatitis c virus genotype 2 infection","volume":"152","author":"Gane","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL recommendations on treatment of hepatitis C 2016","volume":"66","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0065","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00705-016-2865-0","article-title":"Distribution of hepatitis C virus genotypes in volunteer blood donors from Chengdu, China","volume":"161","author":"Gong","year":"2016","journal-title":"Arch. Virol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0070","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/pubmed\/fdr098","article-title":"Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China","volume":"34","author":"Hser","year":"2012","journal-title":"J. Public Health (Oxf.)"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0080","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/phar.1748","article-title":"Ledipasvir-Sofosbuvir: a once-daily oral treatment option for chronic hepatitis c virus genotype 1 infection","volume":"36","author":"Jensen","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12985-015-0341-1","article-title":"Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6","volume":"12","author":"Ju","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.27095","article-title":"HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV","volume":"60","author":"Kanwal","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11262-016-1420-0","article-title":"Assessment of HCV genotypes in Yunnan Province of Southwest China","volume":"53","author":"Li","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0105","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.addbeh.2013.01.010","article-title":"High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan","volume":"38","author":"Ng","year":"2013","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0115","doi-asserted-by":"crossref","first-page":"e9490","DOI":"10.1371\/journal.pone.0009490","article-title":"FastTree 2\u2014approximately maximum-likelihood trees for large alignments","volume":"5","author":"Price","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0120","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jmv.24356","article-title":"Subtype distribution of hepatitis C virus in Jiangsu, China","volume":"88","author":"Qi","year":"2016","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/JCM.02093-14","article-title":"High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods","volume":"53","author":"Quer","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/jgh.12398","article-title":"Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection","volume":"29","author":"Rao","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0135","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00705-014-2185-1","article-title":"Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011","volume":"159","author":"Rong","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0140","doi-asserted-by":"crossref","first-page":"10811","DOI":"10.3748\/wjg.v21.i38.10811","article-title":"Injecting drug use: a vector for the introduction of new hepatitis C virus genotypes","volume":"21","author":"Ruta","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0145","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/1060028014563952","article-title":"Ledipasvir-sofosbuvir: interferon-\/ribavirin-free regimen for chronic hepatitis C virus infection","volume":"49","author":"Smith","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140263","article-title":"The molecular epidemiological study of HCV subtypes among intravenous drug users and non-injection drug users in China","volume":"10","author":"Tao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0160","article-title":"Baseline HCV antibody prevalence and risk factors among drug users in China\u2019s national methadone maintenance treatment program","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0165","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1159\/000481561","article-title":"Genotype distribution and molecular epidemiology of hepatitis c virus in Guangzhou, China: predominance of Genotype 1b and increasing incidence of genotype 6a","volume":"43","author":"Yuan","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0170","article-title":"HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12985-017-0710-z","article-title":"Hepatitis C virus in mainland China with an emphasis on genotype and subtype distribution","volume":"14","author":"Zhang","year":"2017","journal-title":"Virol. J."},{"key":"10.1016\/j.drugalcdep.2018.09.026_bib0180","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/add.12836","article-title":"Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China","volume":"110","author":"Zhou","year":"2015","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618307750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618307750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T12:28:48Z","timestamp":1549283328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618307750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":36,"alternative-id":["S0376871618307750"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.09.026","relation":{},"ISSN":["0376-8716"],"issn-type":[{"type":"print","value":"0376-8716"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus genotype diversity and distribution among methadone maintenance treatment patients in Jiangsu, China","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}